Biofarm S.A. Logo

Biofarm S.A.

A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.

BIO | RO

Overview

Corporate Details

ISIN(s):
ROBIOFACNOR9
LEI:
254900G63HUEZ1Z9UW08
Country:
Romania
Address:
LOGOFĂTUL TĂUTU, 031212 BUCUREȘTI, SECTORUL 3
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1921, Biofarm S.A. is a manufacturer of pharmaceuticals and food supplements. The company is a significant producer of soft gelatin capsules and ranks among the top drug manufacturers in its domestic market. Its portfolio includes over 200 products covering approximately 61 therapeutic areas, such as nutritional supplements, vitamins, and dermatological drugs. Biofarm distributes its products through national partners and also engages in export activities. With over a century of history, the company is a long-standing presence in the pharmaceutical sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-03 15:26
Post-Annual General Meeting Information
Hotararea consiliului de administratie / organe abilitate (in conformitate cu p…
English 160.6 KB
2025-11-03 15:25
Post-Annual General Meeting Information
Hotararea consiliului de administratie / organe abilitate (in conformitate cu p…
Romanian 163.8 KB
2025-10-31 15:28
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 130.4 KB
2025-10-31 15:27
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 133.3 KB
2025-09-24 15:23
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
English 248.0 KB
2025-09-24 15:22
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 219.8 KB
2025-09-24 15:20
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 119.8 KB
2025-09-24 15:19
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 108.5 KB
2025-08-14 17:44
Interim Report
Raport Financiar Semestrial - RFS
Romanian 4.0 MB
2025-08-08 15:30
Notice of Dividend Amount
Plata dividend - RC17
English 200.1 KB
2025-08-08 15:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 224.9 KB
2025-06-25 11:52
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 131.4 KB
2025-06-25 11:50
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 116.7 KB

Automate Your Workflow. Get a real-time feed of all Biofarm S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biofarm S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biofarm S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America APRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.